Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases.

The aim of these studies was to explore the possibility that enhanced triacylglycerol clearance may contribute to the hypotriacylglycerolemic effect of n-3 fatty acids in humans. Healthy subjects (n = 20) and hypertriacylglycerolemic patients (n = 6) were given a placebo (olive oil, OO) or a fish-oil concentrate (FOC; 41% eicosapentaenoic acid and 23% docosahexaenoic acid) in two, independent, randomized, blind trials. For the healthy subjects, the FOC treatment period was 3 wk long and FOC intakes were 5 g/d. For the patients, treatment periods were 4 wk long and dosages were 5 g.70 kg body wt-1.d-1. Washout periods were 2-4 wk for both groups. Blood samples were drawn at the end of each phase and analyzed for plasma lipids, lipoproteins, and endogenous (nonheparin-stimulated) activities of lipoprotein lipase (LPL) and hepatic lipase (HL). In the healthy subjects the FOC decreased plasma triacylglycerol concentrations by 18% (P < 0.01), whereas in the patients concentrations were reduced by 35% (P < 0.05). Low-density-lipoprotein-cholesterol concentrations increased by 25% in the latter group (P = 0.06). FOC increased the endogenous activities of LPL and HL by 62% and 68%, respectively (P < 0.0001), in the healthy subjects, but only LPL in the patients (65%, P < 0.005). These data suggest that endogenous lipase activities may be altered by nutritional interventions, and further, that accelerated lipolysis could contribute, at least in part, to the observed effects of n-3 fatty acids on human lipoprotein metabolism.

[1]  A. Olsson,et al.  Conversion of the electrophoretic pattern of type IV hyperlipidaemia to type III by intravenous heparin. , 2009, Acta medica Scandinavica.

[2]  B. Hustvedt,et al.  N-3 fatty acids and chylomicron metabolism in the rat. , 1997, Journal of lipid research.

[3]  S. Kasim-Karakas,et al.  Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans. , 1995, Metabolism: clinical and experimental.

[4]  A. Hamsten,et al.  Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[5]  C. Packard,et al.  Measurement and physiological significance of lipoprotein and hepatic lipase activities in preheparin plasma. , 1995, Clinical chemistry.

[6]  G. Olivecrona,et al.  A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. , 1994, The Journal of biological chemistry.

[7]  J. Lalouel,et al.  Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. , 1994, The Journal of biological chemistry.

[8]  I. Goldberg,et al.  Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. , 1994, The Journal of biological chemistry.

[9]  M. Huff,et al.  Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil. , 1993, Biochimica et biophysica acta.

[10]  W. Harris,et al.  Modification of lipid-related atherosclerosis risk factors by ω3 fatty acid ethyl esters in hypertriglyceridemic patients , 1993 .

[11]  J. Joven,et al.  Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. , 1993, Journal of lipid research.

[12]  W. Harris,et al.  Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. , 1993, The American journal of clinical nutrition.

[13]  Y. Saito,et al.  Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein. , 1993, European journal of pharmacology.

[14]  S. Eisenberg,et al.  Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. , 1992, The Journal of clinical investigation.

[15]  Y. Arad,et al.  Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. , 1992, The Journal of clinical investigation.

[16]  A. Hamsten,et al.  Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. , 1992, Journal of lipid research.

[17]  R. Eckel,et al.  Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities. , 1992, Journal of lipid research.

[18]  G. Franceschini,et al.  Omega-3 fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers. , 1991, Metabolism: clinical and experimental.

[19]  G. Herzberg The 1990 Borden Award Lecture. Dietary regulation of fatty acid and triglyceride metabolism. , 1991, Canadian journal of physiology and pharmacology.

[20]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Dallongeville,et al.  Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  W. Harris,et al.  Short-term effects of fish oil on human plasma lipid levels , 1991 .

[23]  P. Blackett,et al.  Use of Plasma Lipoprotein Lipase Activity without Heparin Injection for Detection of Homozygous and Heterozygous Lipoprotein Lipase Deficiency , 1991, Annals of the New York Academy of Sciences.

[24]  S. Grundy,et al.  Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia. , 1991, The American journal of clinical nutrition.

[25]  W. Harris,et al.  Effects of fish oil on VLDL triglyceride kinetics in humans. , 1990, Journal of lipid research.

[26]  I. Goldberg,et al.  Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. , 1990, Biochimica et biophysica acta.

[27]  D. Illingworth,et al.  The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study. , 1989, JAMA.

[28]  W. Harris,et al.  Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. , 1989, Journal of lipid research.

[29]  P. Groot,et al.  Effects of diets supplemented with lard fat or mackerel oil on plasma lipoprotein lipid concentrations and lipoprotein lipase activities in domestic swine. , 1989, Atherosclerosis.

[30]  M. Huff,et al.  Dietary Fish Oil Increases Conversion of Very Low Density Lipoprotein Apoprotein B to Low Density Lipoprotein , 1989, Arteriosclerosis.

[31]  F. Karpe,et al.  Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. , 1988, Journal of lipid research.

[32]  R. Zechner,et al.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. , 1988, The Journal of clinical investigation.

[33]  R. Eckel,et al.  Plasma Lipolytic Activity: Relationship to Postheparin Lipolytic Activity and Evidence for Metabolic Regulation , 1988, Diabetes.

[34]  R. Krauss,et al.  Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. , 1988, The Journal of clinical investigation.

[35]  S. Grundy,et al.  Fibric acids: effects on lipids and lipoprotein metabolism. , 1987, The American journal of medicine.

[36]  A. Høstmark,et al.  Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. , 1987, The Journal of nutrition.

[37]  C. Blum,et al.  Association of plasma lipoproteins with postheparin lipase activities. , 1986, The Journal of clinical investigation.

[38]  D. Sullivan,et al.  Triglyceride‐Lowering Effect of Marine Polyunsaturates in Patients with Hypertriglyceridemia , 1985, Arteriosclerosis.

[39]  W. Harris,et al.  Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia , 1985 .

[40]  R. Boston,et al.  Suppression by diets rich in fish oil of very low density lipoprotein production in man. , 1984, The Journal of clinical investigation.

[41]  R. Havel,et al.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W. Harris,et al.  The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oils. , 1983, Metabolism: clinical and experimental.

[43]  I. Goldberg,et al.  Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. , 1982, The Journal of clinical investigation.

[44]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[45]  C. S. Wang,et al.  Modified heparin-Sepharose procedure for determination of plasma lipolytic activities of normolipidemic and hyperlipidemic subjects after injection of heparin. , 1981, Clinical chemistry.

[46]  J. Boberg,et al.  Quantitative determination of hepatic and lipoprotein lipase activities from human postheparin plasma. , 1977, Journal of lipid research.

[47]  H. Greten,et al.  Comparison of assay methods for selective measurement of plasma lipase. The effect of clofibrate on hepatic and lipoprotein lipase in normals and patients with hypertriglyceridemia. , 1977, Atherosclerosis.

[48]  P. Nilsson-ehle,et al.  A stable, radioactive substrate emulsion for assay of lipoprotein lipase. , 1976, Journal of lipid research.

[49]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[50]  H. Engelberg Human endogenous lipemia clearing factor (active factor). , 1955, The American journal of physiology.

[51]  E. Korn Properties of clearing factor obtained from rat heart acetone powder. , 1954, Science.

[52]  P. Hahn ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN. , 1943, Science.

[53]  P. Clifton,et al.  Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. , 1990, Arteriosclerosis.